Copyright: ©Author(s) 2026.
World J Diabetes. Apr 15, 2026; 17(4): 115437
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.115437
Published online Apr 15, 2026. doi: 10.4239/wjd.v17.i4.115437
Figure 3 Effect of nephrocystin-4 on HK-2 cell proliferation and apoptosis.
A and B: Measurement of nephrocystin-4 knockdown and overexpression efficiency in HK-2 cells by real-time quantitative polymerase chain reaction; C: Measurement of HK-2 cell viability by cell counting kit-8 assay; D: Measurement of HK-2 cell apoptosis by TUNEL staining. Scale bar = 20 µm. Data are presented as mean ± SD (n = 3). bP < 0.01, cP < 0.001. HG: High glucose; NPHP4-OE: Overexpression of nephrocystin-4; siNPHP4: Small interfering RNA targeting nephrocystin-4.
- Citation: Si W, Dai Y, Hu GP, Zhang Q, Lv F, Zhang Q. EP300 drives renal fibrosis in diabetic nephropathy via histone acetyltransferase-mediated nephrocystin-4 expression. World J Diabetes 2026; 17(4): 115437
- URL: https://www.wjgnet.com/1948-9358/full/v17/i4/115437.htm
- DOI: https://dx.doi.org/10.4239/wjd.v17.i4.115437